Kloxxado 8 mg in 0.1 mL Nasal Spray
RxNorm 2540709
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2540709 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Kloxxado 8 mg in 0.1 mL Nasal Spray.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Kloxxado 8 mg in 0.1 mL Nasal Spray
(Atom ID: 12630128)
SYPrescribable
Synonym (SY):
Kloxxado 8 mg per 0.1 mL Nasal Spray
(Atom ID: 12630130)
SYPrescribable
Synonym (SY):
Kloxxado 80 mg/ML Nasal Spray
(Atom ID: 12630129)
SBDPrescribable
Semantic Branded Drug (SBD):
Naloxone hydrochloride 80 mg/ML Nasal Spray [Kloxxado]
(Atom ID: 12630127)
Patient Education
Naloxone Nasal Spray
Naloxone nasal spray is used along with emergency medical treatment to reverse the life-threatening effects of a known or suspected opiate (narcotic) overdose in adults and children. Naloxone nasal spray is in a class of medications called opiate antagonists. It works by blocking the effects of opiates to relieve dangerous symptoms caused by high levels of opiates in the blood.
[Learn More]
* Please review the disclaimer below.